Cerora, founded with a mission to revolutionize neurodiagnostics, is a healthcare IT company specializing in providing diagnostic information for concussions (mTBI) and Alzheimer’s disease. The company envisions a future where objective biosensors play a crucial role in brain health diagnostics. Cerora offers advanced neuro-related diagnostic tools and services, focusing on leveraging cutting-edge technology to improve the accuracy and accessibility of brain health assessments.
Notable figures affiliated with Cerora include members of its Corporate and Scientific Advisory Boards, who bring extensive expertise in healthcare and technology. The company has achieved significant milestones in developing and deploying its biosensor technology, making a notable impact on the early detection and management of neurological conditions. Cerora's innovative approach has positioned it as a key player in the neurodiagnostic market, contributing to advancements in brain health diagnostics.
